Moderna Pauses mRNA RSV Vaccine Trial For Children

Health & LifestyleNewsPublisher's Picks
497

Listen to article (english)

Translate to Spanish or other 102 languages!

In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. Image for illustration purposes
In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Jon Cohen / Science.org

Recently approved adult vaccines against respiratory syncytial virus (RSV) are already saving lives. But prospects have dimmed for some infant vaccines against the virus, which each year kills up to 100,000 children under age 5 around the world and is the leading cause of infant hospitalizations in the United States. In recent clinical trials, two experimental RSV vaccines for babies may not only have failed to protect them, but actually made some of them sicker when they got RSV or another respiratory virus. 

Follow the link below for the full story:

- Advertisement -

https://www.science.org/content/article/safety-signal-moderna-s-rsv-vaccine-studies-halts-trials-other-vaccines-childhood

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Stay-At-Home Mom Turns Her Life Around At STC 
Next article
Help Loved Ones Seek Support, Medical Help Early for Holiday Anxiety, Depression

More Articles

The Truth About Pricey Skin and Hair Care Products

Mega Doctor News CLEVELAND CLINIC - When it comes to hair and skincare...

STHS Children’s Partners with Disney On Ice to Create Magical Moments for Pediatric Patients

From timeless heroes like Ariel, Moana and Snow White to lovable animal friends such as Sebastian and Mushu—and even familiar villains like Maleficent—Disney characters have been inspiring smiles and sparking imagination for generations of families around the world.

DHR Health Welcomes Double Board-Certified Vascular Surgeon, Dr. Gabriel Gonzalez

Mega Doctor News EDINBURG, Texas - DHR Health, one of the largest physician-owned...

Elevated Antibodies Complicate Donor Matching for Transplant Patients

People who have elevated levels of donor-specific anti-HLA antibodies (DSAs) — immune system proteins that can target and attack donor stem cells — wait an average of three additional months to receive blood or bone marrow transplants from a healthy donor.
- Advertisement -